IKT logo

Inhibikase Therapeutics (IKT) Current Assets

Annual Current Assets

$14.21 M
-$10.16 M-41.69%

December 31, 2023


Summary


Performance

IKT Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIKTbalance sheetmetrics:

Quarterly Current Assets

$4.19 M
-$4.41 M-51.29%

September 30, 2024


Summary


Performance

IKT Quarterly Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherIKTbalance sheetmetrics:

Current Assets Formula

Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets

IKT Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-41.7%-51.3%
3 y3 years-3.9%-84.8%
5 y5 years+1035.4%-84.8%

IKT Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-66.5%at low-90.1%at low
5 y5-year-66.5%>+9999.0%-91.5%>+9999.0%
alltimeall time-66.5%>+9999.0%-91.5%>+9999.0%

Inhibikase Therapeutics Current Assets History

DateAnnualQuarterly
Sep 2024
-
$4.19 M(-51.3%)
Jun 2024
-
$8.60 M(-20.4%)
Mar 2024
-
$10.81 M(-23.9%)
Dec 2023
$295.60 K(-47.7%)
$14.21 M(-19.0%)
Sep 2023
-
$17.55 M(-20.2%)
Jun 2023
-
$21.98 M(-20.4%)
Mar 2023
-
$27.63 M(+13.4%)
Dec 2022
$565.20 K
$24.37 M(-12.9%)
Sep 2022
-
$27.99 M(-17.6%)
Jun 2022
-
$33.95 M(-11.6%)
DateAnnualQuarterly
Mar 2022
-
$38.39 M(-9.6%)
Dec 2021
$0.00(0.0%)
$42.47 M(-7.4%)
Sep 2021
-
$45.87 M(-6.8%)
Jun 2021
-
$49.22 M(+314.6%)
Mar 2021
-
$11.87 M(-19.7%)
Dec 2020
$0.00(-100.0%)
$14.78 M(>+9900.0%)
Sep 2020
-
$29.90 K(-1.3%)
Jun 2020
-
$30.30 K(+12.2%)
Mar 2020
-
$27.00 K(-23.7%)
Dec 2019
$2900.00(-99.8%)
$35.40 K
Dec 2018
$1.59 M
-

FAQ

  • What is Inhibikase Therapeutics annual total current assets?
  • What is the all time high annual current assets for Inhibikase Therapeutics?
  • What is Inhibikase Therapeutics annual current assets year-on-year change?
  • What is Inhibikase Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Inhibikase Therapeutics?
  • What is Inhibikase Therapeutics quarterly current assets year-on-year change?

What is Inhibikase Therapeutics annual total current assets?

The current annual current assets of IKT is $14.21 M

What is the all time high annual current assets for Inhibikase Therapeutics?

Inhibikase Therapeutics all-time high annual total current assets is $42.47 M

What is Inhibikase Therapeutics annual current assets year-on-year change?

Over the past year, IKT annual total current assets has changed by -$10.16 M (-41.69%)

What is Inhibikase Therapeutics quarterly total current assets?

The current quarterly current assets of IKT is $4.19 M

What is the all time high quarterly current assets for Inhibikase Therapeutics?

Inhibikase Therapeutics all-time high quarterly total current assets is $49.22 M

What is Inhibikase Therapeutics quarterly current assets year-on-year change?

Over the past year, IKT quarterly total current assets has changed by -$4.41 M (-51.29%)